bbc.co.uk · 2 min
Massive hope for pancreatic cancer pill after trial saw tumours vanishA KRAS inhibitor pill called daraxonrasib, already approved in the US, has shown tumor response rates high enough that some patients saw their pancreatic cancer vanish. The BBC reports the drug nearly doubled disease control duration, which could be a genuine breakthrough for one of the deadliest cancers.


